Antihistamines
INDIVIDUAL AGENTS
First-generation sedating antihistamine.
Licensed indications include symptomatic control of allergic conditions that respond to antihistamines, such as hay fever and urticaria.
Sedation and impaired concentration are the main sport-relevant effects. Impairment can be present without the athlete feeling drowsy.
Reduced sweating may add to heat strain in hot or humid conditions. Inferred from anticholinergic pharmacology, not a labelled effect.
Common in over-the-counter cold and flu combinations, where co-ingredients need separate checking.
Form: Oral tablets and oral solution. Parenteral formulations exist and are not covered here.
Route: Oral
Legal category: P
Travel: Tablets: no restrictions. Oral solutions: check airline carry-on requirements for liquids. Carry original packaging with dispensing label.
Sedation and psychomotor impairment are the main timing considerations. Anticholinergic effects may seriously affect the ability to drive and use machinery. Effects on reaction time, coordination and concentration may be present when training, competing or travelling, including the morning after an evening dose.
Sedation: Drowsiness, dizziness, blurred vision and psychomotor impairment.
Skill and reaction-time tasks: Reaction time, coordination and concentration may be reduced, with or without the athlete feeling drowsy.
Heat: Reduced sweating may add to heat strain in hot or humid conditions. Inferred from anticholinergic pharmacology, not a labelled effect.
Daytime sedation may affect training quality and daytime function.
Dry mouth is common. Urinary retention is listed with unknown frequency.
Effects on sleep architecture are not claimed here.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
Alcohol: Effects may be increased. Avoid concurrent use.
Hypnotics and anxiolytics: Increased sedative effect.
Phenytoin: Chlorphenamine inhibits its metabolism and can lead to phenytoin toxicity.
MAOIs: Anticholinergic effects intensified. Contraindicated within 14 days.
Other antihistamine-containing products: Avoid duplication, including cough and cold products.
Sedating supplements (for example melatonin, valerian): Additive sedation is plausible and not directly studied.
WADA: Not Prohibited 2026.
Combination products (for example with decongestants, caffeine or analgesics) have separate anti-doping and performance implications. Check every ingredient of the dispensed product on GlobalDRO.
P in the UK. Pharmacy supervision required.
Product names and availability vary by country. Verify local requirements before international travel or competition. Check combination products on GlobalDRO.
Approximately £0.03 per 4mg tablet.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com
First-generation sedating phenothiazine antihistamine.
Licensed indications include symptomatic treatment of allergic conditions of the upper respiratory tract and skin, antiemetic use, and short-term treatment of insomnia in adults. Sominex is licensed for correction of temporary disturbances of sleep pattern.
More sedating than chlorphenamine, with effects lasting up to 12 hours. Next-day effects on alertness, reaction time and coordination are a particular concern.
Reduced sweating may add to heat strain in hot or humid conditions. Inferred from anticholinergic pharmacology, not a labelled effect.
Also used for travel sickness and sleep, so use may fall outside allergy care.
Form: Oral tablets (10mg, 25mg), oral solution and solution for injection. Parenteral use is not covered here.
Route: Oral
Legal category: P/POM
Travel: Tablets: no restrictions. Oral solutions: check airline carry-on requirements for liquids. Carry original packaging with dispensing label.
Effects can last up to 12 hours. Sedation, dizziness and blurred vision may be present when training, competing or travelling, including the morning after an evening dose.
Sedation: Sedation or somnolence is very common. Dizziness and blurred vision are also reported.
Skill and reaction-time tasks: Reaction time, coordination and concentration may be reduced.
Heat: Reduced sweating may add to heat strain in hot or humid conditions. Inferred from anticholinergic pharmacology, not a labelled effect.
QT interval: Phenothiazines may prolong the QT interval. Consider where an athlete has other QT-relevant factors.
Photosensitivity: Avoid strong sunlight and UV light during treatment and shortly after, relevant to outdoor training.
Daytime sedation may affect training quality and daytime function.
Dry mouth, constipation and urinary retention are reported, each with unknown frequency.
Effects on sleep architecture are not claimed here.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
Alcohol: Intensifies sedation. Avoid.
Sedatives, hypnotics, tricyclic antidepressants and anticholinergics: Effects enhanced.
Antipsychotics: Increased risk of neuroleptic malignant syndrome.
QT-prolonging drugs: Caution.
CYP2D6 substrates (for example amitriptyline): Levels may rise.
Drugs that lower seizure threshold: Caution.
MAOIs: Avoid within 14 days.
Magnesium, aluminium and calcium antacids: Separate by at least 2 hours.
Sedating supplements (for example melatonin, valerian): Additive sedation is plausible and not directly studied.
Skin allergy testing and urine pregnancy tests: Stop at least 72 hours before skin tests (false negatives). May cause false results in immunological urine pregnancy tests.
WADA: Not Prohibited 2026.
Combination products (for example with decongestants, caffeine or analgesics) have separate anti-doping and performance implications. Check every ingredient of the dispensed product on GlobalDRO.
P/POM in the UK.
Product names, legal category and availability vary by country, and sleep-aid versions differ by market. Verify local requirements before international travel or competition.
Approximately £0.03 per 10mg tablet and £0.04 per 25mg tablet. Sominex 20mg (P) is approximately £0.24 per tablet in the pack of 8 and £0.17 in the pack of 16.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com
INDIVIDUAL AGENTS
Second-generation antihistamine.
Licensed indications include relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis and relief of symptoms of chronic idiopathic urticaria.
Somnolence is reported more often than with placebo, making it the agent in this class most associated with sedation.
Caution is advised with alcohol and other CNS depressants.
Form: Oral tablets (10mg) and oral solution.
Route: Oral
Legal category: GSL/P/POM
Travel: Tablets: no restrictions. Oral solutions: check airline carry-on requirements for liquids. Carry original packaging with dispensing label.
Somnolence is reported more often than with placebo. Driving tests showed no clinically relevant effects at the recommended dose, but patients who experience somnolence are advised against hazardous activities and machinery. Alertness may be affected around training, competition and travel.
Somnolence: The main concern. Mild to moderate in most cases.
CNS depressants: Alcohol and other CNS depressants may cause additional reductions in alertness.
Epilepsy: Caution in epilepsy or risk of convulsions.
Daytime somnolence may affect daytime function.
Caution where there is a predisposition to urinary retention, as cetirizine may increase that risk.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
Alcohol: Precaution recommended. No clinically significant interaction at therapeutic doses.
Other CNS depressants: Additional reduction in alertness.
Pseudoephedrine and theophylline: No interaction found.
Allergy testing: A 3-day wash-out is needed beforehand.
WADA: Not Prohibited 2026.
Combination products (for example with decongestants, caffeine or analgesics) have separate anti-doping and performance implications. Check every ingredient of the dispensed product on GlobalDRO.
GSL/P/POM in the UK, depending on pack size.
Product names, legal category and availability vary by country. Verify local requirements before international travel or competition.
Approximately £0.02 per 10mg tablet.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com
Second-generation antihistamine.
Licensed indications include relief of symptoms of allergic rhinitis and urticaria in adults and adolescents aged 12 years or older.
The SmPC describes no or negligible influence on the ability to drive and use machines. Fatigue is common and somnolence is very rare.
Form: Oral tablets (5mg).
Route: Oral
Legal category: POM
Travel: No restrictions. Carry original packaging with dispensing label.
The SmPC describes no or negligible influence on the ability to drive and use machines. Fatigue is common, so alertness and energy may be affected around training, competition and travel.
Fatigue: Common. Somnolence is very rare.
Seizures: Caution with a medical or familial history of seizures.
Fatigue may affect daytime function and training tolerance.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
Alcohol: Caution advised. Cases of alcohol intolerance and intoxication have been reported after marketing.
Erythromycin and ketoconazole: No clinically relevant interaction seen in trials.
WADA: Not Prohibited 2026.
POM in the UK. Prescription required.
Product names, legal category and availability vary by country. Verify local requirements before international travel or competition.
Approximately £0.05 per 5mg tablet.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com
Second-generation antihistamine.
Licensed indications include relief of symptoms of seasonal allergic rhinitis (120mg) and of chronic idiopathic urticaria (180mg), in adults and children aged 12 years and older.
Drowsiness is common and reported at a rate similar to placebo. The SmPC states it is unlikely to affect the ability to drive or use machines.
Form: Oral tablets (120mg, 180mg).
Route: Oral
Legal category: P/POM
Travel: No restrictions. Carry original packaging with dispensing label.
The SmPC states it is unlikely to affect the ability to drive or use machines. Individual response is worth knowing before complex tasks. Aluminium and magnesium antacids should be separated by 2 hours.
Drowsiness: Common, at a rate similar to placebo in trials.
Cardiovascular: Antihistamines as a class have been associated with tachycardia and palpitations, relevant in patients with cardiovascular disease.
Headache and dizziness are common. No other recovery-specific effects are described.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
Aluminium and magnesium hydroxide antacids: Reduced absorption. Leave 2 hours between doses.
Erythromycin and ketoconazole (P-gp inhibitors): 2 to 3 times increase in plasma fexofenadine levels.
Apalutamide (weak P-gp inducer): Lowers exposure.
WADA: Not Prohibited 2026.
P/POM in the UK, depending on strength.
Product names, legal category and availability vary by country. Verify local requirements before international travel or competition.
Approximately £0.04 per 120mg tablet and £0.10 per 180mg tablet.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com
Second-generation antihistamine.
Licensed indications include symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
The SmPC describes no or negligible influence on the ability to drive and use machines, although some people may feel drowsy. Somnolence was the most frequent reaction above placebo in adult trials.
Form: Oral tablets (10mg) and oral solution.
Route: Oral
Legal category: GSL/P/POM
Travel: Tablets: no restrictions. Oral solutions: check airline carry-on requirements for liquids. Carry original packaging with dispensing label.
The SmPC describes no or negligible influence on the ability to drive and use machines. Some people may feel drowsy, which could affect alertness around training, competition and travel.
Somnolence: The most frequent reaction above placebo in adult trials.
Fatigue is listed as very rare. No other recovery-specific effects are described.
Selected interactions relevant to common athlete use patterns. Not exhaustive. See SmPC for full interaction profile.
CYP3A4 and CYP2D6 inhibitors: May raise loratadine levels and increase adverse events.
Alcohol: No potentiating effect on psychomotor performance was found.
Skin allergy testing: Stop at least 48 hours beforehand.
WADA: Not Prohibited 2026.
Combination products (for example with decongestants, caffeine or analgesics) have separate anti-doping and performance implications. Check every ingredient of the dispensed product on GlobalDRO.
GSL/P/POM in the UK, depending on pack size.
Product names, legal category and availability vary by country. Verify local requirements before international travel or competition.
Approximately £0.02 per 10mg tablet.
Verify current pricing at bnf.nice.org.uk.
Excipients vary by manufacturer. Verify per dispensed product.
Vegetarian: Verify per dispensed product.
Vegan: Verify per dispensed product.
Halal: Verify per dispensed product.
Kosher: Verify per dispensed product.
For product-specific allergen or excipient queries, contact info@medsontrack.com